NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Hyundai Pharm (KO: 004310)

 
004310 Technical Analysis
4
As on 17th Sep 2025 004310 STOCK Price closed @ 3985.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3927.32 & Strong Buy for SHORT-TERM with Stoploss of 3799.55 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

004310STOCK Price

Open 3995.00 Change Price %
High 4035.00 1 Day -10.00 -0.25
Low 3970.00 1 Week -10.00 -0.25
Close 3985.00 1 Month 175.00 4.59
Volume 301030 1 Year 125.00 3.24
52 Week High 5820.00 | 52 Week Low 3000.00
 
KO Korea Most Active Stocks
093230 33.00 -49.23%
093230 33.00 -49.23%
152550 383.00 19.69%
152550 383.00 19.69%
096300 156.00 -6.02%
096300 156.00 -6.02%
168490 159.00 29.27%
168490 159.00 29.27%
011930 1778.00 4.59%
011930 1778.00 4.59%
 
KO Korea Top Gainers Stocks
119650 1581.67 244.59%
119650 1581.67 244.59%
168490 159.00 29.27%
168490 159.00 29.27%
152550 383.00 19.69%
152550 383.00 19.69%
047810 115000.00 14.77%
047810 115000.00 14.77%
033240 22400.00 13.42%
033240 22400.00 13.42%
 
KO Korea Top Losers Stocks
002210 973.00 -65.00%
002210 973.00 -65.00%
002210 973.00 -65.00%
009275 1800.00 -64.50%
009275 1800.00 -64.50%
010145 6580.00 -60.83%
010145 6580.00 -60.83%
093230 33.00 -49.23%
093230 33.00 -49.23%
001745 3600.00 -46.27%
 
 
004310
Daily Charts
004310
Intraday Charts
Whats New @
Bazaartrend
004310
Free Analysis
 
004310 Important Levels Intraday
RESISTANCE4110.26
RESISTANCE4070.09
RESISTANCE4045.26
RESISTANCE4020.43
SUPPORT3949.58
SUPPORT3924.75
SUPPORT3899.92
SUPPORT3859.75
 
004310 Forecast September 2025
4th UP Forecast4274.05
3rd UP Forecast4181.35
2nd UP Forecast4124.05
1st UP Forecast4066.75
1st DOWN Forecast3903.25
2nd DOWN Forecast3845.95
3rd DOWN Forecast3788.65
4th DOWN Forecast3695.95
 
004310 Weekly Forecast
4th UP Forecast4264.42
3rd UP Forecast4174.81
2nd UP Forecast4119.42
1st UP Forecast4064.03
1st DOWN Forecast3905.98
2nd DOWN Forecast3850.59
3rd DOWN Forecast3795.20
4th DOWN Forecast3705.59
 
004310 Forecast2025
4th UP Forecast10970.4
3rd UP Forecast8730.13
2nd UP Forecast7345.38
1st UP Forecast5960.63
1st DOWN Forecast2009.38
2nd DOWN Forecast624.63
3rd DOWN Forecast-760.13
4th DOWN Forecast-3000.38
 
 
004310 Other Details
Segment EQ
Market Capital 167270400000.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
004310 Address
004310
 
004310 Latest News
 
Your Comments and Response on Hyundai Pharm
 
004310 Business Profile
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical equipment in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antiviral, cardiovascular, central nervous system, contraceptive, depilatory, dermatological, diagnostic, digestive system, endocrine system, ENT, hemostatic, hormone therapy, musculo-skeletal system, ophthalmic, oral disease, respiratory, urogenital system, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial, arthritis, constipation, disinfectant, lip care, nutrition, and wound healing. It also develops products for the treatment of type 2 diabetes, bronchitis, senile disease, and osteoporosis. The company was founded in 1965 and is headquartered in Seoul, South Korea. Address: Hyundai Pharm Building, Seoul, South Korea, 06121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service